Thereafter, despite relatively stable levels of ACPA-IgG toward the time of relapse of RA, avidity maturation was observed in the ACPA nonresponders, with a median of 1.12 M (range 1.12 to 3.60 M). The gene discussed is PRTN3; the disease is rheumatoid arthritis.